Free Trial

Cisco 7Pt Guidance, Astrazeneca 4Pt on Tap, AbbVie Filing

PIPELINE
  • Date $MM Issuer (Priced *, Launch #)
  • 2/21 $Benchmark Cisco Systems 2Y +55a, 3Y +65a, 5Y +80a, 7Y +90a, 10Y +100a, 30Y +115a, 40Y +125a
  • 2/21 $Benchmark Astrazeneca 3Y +65a, 5Y +80a, 7Y +85a, 10Y +95a
  • 2/21 $2B Federal Rep of Germany (KFW) 10Y +51
  • 2/21 $1.5B #NWB (Nederlandse Waterschapsbank) 5Y SOFR+46
  • 2/21 $1.5B #Nordic Investment Bank (NIB) 5Y +37
  • 2/21 $500M CMPC WNG 10Y +215a
  • 2/21 $Benchmark First Abu Dhabi Bank 5Y +90a
  • 2/21 $Benchmark AbbVie investor calls, filed to offer notes for Immunogen deal
  • 2/21 $Benchmark Boston Scientific 5Y, 8Y investor calls

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.